Pratia Prague s.r.o.

The medical center is at the forefront of research in rheumatology and autoimmune disorders, focusing on innovative treatments for conditions such as Axial Spondyloarthritis and Psoriatic Arthritis. Through extensive studies, the center evaluates the long-term safety and efficacy of novel therapeutics like Bimekizumab and Deucravacitinib.

• Axial Spondyloarthritis
• Psoriatic Arthritis

These efforts contribute significantly to improving patient outcomes and advancing therapeutic options in the management of chronic inflammatory conditions.

In the field of dermatology, the center is pioneering research on atopic dermatitis, focusing on the long-term safety and efficacy of treatments like Amlitelimab. This research aims to enhance the quality of life for patients suffering from moderate to severe forms of this condition.

• Atopic Dermatitis

The center's work in this area is crucial for developing sustainable and effective treatment strategies for chronic skin disorders.

The center is actively engaged in neurology research, particularly in the prevention and management of migraine. Studies on Atogepant are conducted to assess its long-term safety and tolerability, offering new hope for individuals with chronic or episodic migraine.

• Chronic or Episodic Migraine

This research is instrumental in providing new insights and therapeutic options for migraine sufferers worldwide.

In the realm of orthopedics, the center is exploring innovative treatments for knee osteoarthritis. The evaluation of PPV-06 Active Immunotherapy focuses on improving pain management and physical function in patients, aiming to enhance their mobility and quality of life.

• Knee Osteoarthritis

These studies are pivotal in advancing the understanding and treatment of degenerative joint diseases.